CDN transporter collaboration with David Raulet published in Nature

Cells have many ways to figure out that something is wrong. One of these is cGAS, which makes a cyclic dinucleotide (CDN) to activate STING innate immune signaling. CDNs are made during bacterial infection and tumor progression, and CDN derivatives are in development to re-activate immune cells next to a tumor. But how do CDNs secreted into the environment get into a target cell? This was the question asked by David Raulet’s lab, who collaborated with us on a genome-wide CRISPRi screen to find the CDN transporter. We helped the Raulet lab identify the folate transporter (SLC19A1) as a CDN importer. The Raulet lab plus further collaboration with Joshua Woodward’s lab figured out the mechanism. Lingyin Li’s lab also identified the folate transporter in a parallel collaboration with Mike Bassik, reported in Molecular Cell. Congrats to former lab members Benjamin Gowen and Stacia Wyman, who were authors on the paper, now out in Nature!

SUBMIT A COMMENT

Your email address will not be published. Required fields are marked *

Filters

Latest News

October 22, 2026

New study reveals how PARP can limit prime editing-mediated insertions-published in THE CRISPR JOURNAL

Prime editing enables precise modifications to DNA without introducing double-strand breaks, offering exciting opportunities for genome engineering....

October 15, 2026

CRISPR IN CLINICAL ONCOLOGY: FROM RESEARCH TO CANCER DIAGNOSTICS AND THERAPIES – PUBLISHED IN NATURE REVIEWS CLINICAL ONCOLOGY

CRISPR technologies have transformed biomedical research, opening new possibilities for understanding, diagnosing, and treating cancer. But how close...

October 15, 2026

Choosing the right tool for precise genome editing – published in Nature Reviews Molecular Cell Biology

The genome-editing toolbox is rapidly expanding, offering increasingly diverse ways to make precise changes to DNA. But with so many emerging technologies,...

News Archive